Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of Friday, August 28, 2026.
OPERATING CASH FLOW YIELD
N/A
Roche Holding AG
Market Cap
$359.46B
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$358.76B
Operating Cash Flow Yield
7.55%
TTM Avg
7.33%
3Y Avg
6.20%
5Y Avg
6.07%
Market Cap
$369.34B
Operating Cash Flow Yield
5.28%
TTM Avg
6.61%
3Y Avg
6.72%
5Y Avg
6.73%
Market Cap
$455.87B
Operating Cash Flow Yield
4.19%
TTM Avg
5.04%
3Y Avg
6.21%
5Y Avg
7.39%
Market Cap
$255.15B
Operating Cash Flow Yield
5.32%
TTM Avg
5.15%
3Y Avg
5.11%
5Y Avg
4.68%
Market Cap
$235.85B
Operating Cash Flow Yield
5.21%
TTM Avg
6.35%
3Y Avg
6.13%
5Y Avg
6.53%
Market Cap
$234.38B
Operating Cash Flow Yield
3.85%
TTM Avg
4.01%
3Y Avg
4.19%
5Y Avg
4.17%
Market Cap
$205.42B
Operating Cash Flow Yield
9.81%
TTM Avg
8.88%
3Y Avg
5.60%
5Y Avg
4.83%
Market Cap
$193.04B
Operating Cash Flow Yield
4.98%
TTM Avg
4.89%
3Y Avg
4.24%
5Y Avg
4.57%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Roche Holding AG (RHHBY) | $359.46B | N/A | N/A | N/A | N/A |
| UnitedHealth Group Incorporated (UNH)vs › | $358.76B | 7.55% | 7.33% | 6.20% | 6.07% |
| Merck & Co., Inc. (MRK)vs › | $369.34B | 5.28% | 6.61% | 6.72% | 6.73% |
| AbbVie Inc. (ABBV)vs › | $455.87B | 4.19% | 5.04% | 6.21% | 7.39% |
| AstraZeneca PLC (AZN)vs › | $255.15B | 5.32% | 5.15% | 5.11% | 4.68% |
| Amgen Inc. (AMGN)vs › | $235.85B | 5.21% | 6.35% | 6.13% | 6.53% |
| Thermo Fisher Scientific Inc. (TMO)vs › | $234.38B | 3.85% | 4.01% | 4.19% | 4.17% |
| Novo Nordisk A/S (NVO)vs › | $205.42B | 9.81% | 8.88% | 5.60% | 4.83% |
| Abbott Laboratories (ABT)vs › | $193.04B | 4.98% | 4.89% | 4.24% | 4.57% |
| Gilead Sciences, Inc. (GILD)vs › | $184.82B | 7.36% | 6.35% | 7.77% | 9.12% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
